Glenmark Pharmaceuticals said it will introduce a 400 mg version of oral antiviral FabiFlu, for the treatment of mild to moderate COVID-19 in India. The […]
Tag: Glenmark
Favipiravir: Phase 3 Clinical Trial
Top-line results from a Phase 3 clinical trial of Favipiravir in mild to moderate COVID-19 patients have been announced by Glenmark Pharmaceuticals Limited. The trial […]
Glenmark calls overpricing charge baseless- Fabiflu
In a strong-worded reaction to the Drugs Controller General of India (DCGI)’s move to pull up drug major Glenmark on charges of alleged overpricing, false and misleading claims related […]
Glenmark launches Hypertension Awareness symbol
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, launched the world’s first hypertension awareness symbol, in collaboration with Association of Physicians of India (API) and […]
FabiFlu: Glenmark commences PMS study
Glenmark has announced a price reduction of 27% for FabiFlu. The new MRP is Rs 75 per tab from the earlier Rs 103 per tab. […]